4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-002674
General Counsel and Secretary sold 6,843 shares at $35.66 ($244,021)
- General Counsel and Secretary acquired 6,843 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara General Counsel and Secretary | 2023-01-23 | Option exercise | +4,971 | $23.03 | $114,482 | 4,971 | D |
| Meisner Lara General Counsel and Secretary | 2023-01-23 | Option exercise | +1,872 | $14.00 | $26,208 | 6,843 | D |
| Meisner Lara General Counsel and Secretary | 2023-01-23 | Sale | −6,843 | $35.66 | $244,021 | 0 | D |
| Derivatives | |||||||
| Meisner Lara General Counsel and Secretary | 2023-01-23 | Option exercise · Stock Option (Right to Buy) | −4,971 | 39,750 | D | ||
| Meisner Lara General Counsel and Secretary | 2023-01-23 | Option exercise · Stock Option (Right to Buy) | −1,872 | 20,003 | D | ||
| Open-market sales · 6,843 sh · avg $35.66 · $244,021 | |||||||
Loading xslF345X03/doc4.xml…